Sophie Ross

1 week ago | medium.com | Sophie Ross

In an increasingly competitive DeFi landscape, investors are constantly looking for smarter ways to make their crypto assets work for them. One of the most effective strategies is staking — locking tokens to support a network and earn passive income in return. If you’re looking to stake FTY from FutarchyDAO, StakingRewards offers an edge that few platforms can match: boosted APYs, transparent analytics, and deep market intelligence — all designed to help you earn more with less friction.

2 weeks ago | bmj.com | Sophie Ross |Nicolas Pinto-Sander |Collins Iwuji

Sophie Ross, specialist registrar genitourinary medicine1, Nicolas Pinto-Sander, consultant sexual health and HIV medicine1, Collins Iwuji, honorary consultant physician, professor of global health and HIV medicine12 1University Hospitals Sussex NHS Foundation Trust, Brighton, UK 2Department of global health and infection, Brighton and Sussex Medical School, University of Sussex, Brighton Correspondence to: S Ross sophie.ross5{at}nhs.net Increasing incidence of gonorrhoea is likely to lead to...

2 months ago | ftitechnology.com | Sophie Ross

In high stakes discovery and investigations, in-house legal teams and law firms are often overloaded with challenges in uncovering key information, insights and risks across complex data types and large document populations. Meanwhile, demand for artificial intelligence solutions is surging in the legal field, with lawyers chasing clarity around how they can leverage emerging technology in practical, responsible ways.

2 months ago | news.bloomberglaw.com | Sophie Ross

Legal department leaders are increasingly exploring how generative artificial intelligence can increase efficiency and innovation. However, gaps between the practical, technical aspects of applying generative AI; the best practices for doing so; and abstract regulatory guidance make it difficult to balance rapid innovation with responsible risk mitigation.

Oct 17, 2024 | biorxiv.org | Jiahe Tian |Sophie Ross |Benjamin Ciener |Sandra Leskinen

AbstractHuman brain tissue studies have historically used a range of metrics to assess RNA quality. However, few large-scale cross-comparisons of pre-sequencing quality metrics with RNA-seq quality have been published.